CUSIP N62509109ORDINARY SHARESQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
182 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 16.94M | $594.39M | +241.8K | Added |
| 2 | Capital World Investors | 9.98M | $350.24M | +161.3K | Added |
| 3 | Ra Capital Management, L.P. | 9.55M | $335.02M | −588.7K | Reduced |
| 4 | Fcpm III Services B.V. | 9.20M | $322.70M |
| −13.5K |
| Reduced |
| 5 | Bain Capital Life Sciences Investors, LLC | 7.31M | $256.31M | −3.41M | Reduced |
| 6 | Fmr LLC | 6.41M | $224.97M | +877.7K | Added |
| 7 | Wellington Management Group LLP | 5.03M | $176.56M | +1.01M | Added |
| 8 | Viking Global Investors LP | 4.20M | $147.46M | −2.27M | Reduced |
| 9 | Deerfield Management Company, L.P. | 4.16M | $146.10M | −101.9K | Reduced |
| 10 | Jennison Associates LLC | 3.49M | $122.40M | −709.3K | Reduced |
See every fund holding Newamsterdam Pharma Company, with full quarter-over-quarter share changes.
Unlock all holders